Search research articles
Contact Us
Filters
Showing results (301-310 of 320) with videos related to
Page
of 32
Sort By:
Heart (British Cardiac Society)
|
September 30, 2015
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
Noemi Pavo, Markus Raderer, Martin Hülsmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group
Peter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2022
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)
Matti Aapro, Zoe Caprariu, Petio Chilingirov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
G G Steger, R Greil, A Lang, et al.
Oncotarget
|
November 9, 2017
Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients
Noemi Pavo, Markus Raderer, Georg Goliasch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
M Gnant, M Filipits, R Greil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M Gnant, B Mlineritsch, H Stoeger, et al.
Cancer Medicine
|
March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies
Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
Breast Care (Basel, Switzerland)
|
June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2023
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Ana-Alicia Beltran-Bless, Mark J Clemons, Christian Fesl, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 320) with videos related to
Sort By:
Page
of 32
Heart (British Cardiac Society)
|
September 30, 2015
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
Noemi Pavo, Markus Raderer, Martin Hülsmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group
Peter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2022
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)
Matti Aapro, Zoe Caprariu, Petio Chilingirov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
G G Steger, R Greil, A Lang, et al.
Oncotarget
|
November 9, 2017
Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients
Noemi Pavo, Markus Raderer, Georg Goliasch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
M Gnant, M Filipits, R Greil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M Gnant, B Mlineritsch, H Stoeger, et al.
Cancer Medicine
|
March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies
Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
Breast Care (Basel, Switzerland)
|
June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2023
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Ana-Alicia Beltran-Bless, Mark J Clemons, Christian Fesl, et al.
Page
of 32